Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna Exact Sciences Corp Transaction History
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
- $250 Billion
- Q3 2025
A detailed history of Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna transactions in Exact Sciences Corp stock. As of the latest transaction made, Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna holds 2,400 shares of EXAS stock, worth $160,872. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,400
Previous 2,400
-0.0%
Holding current value
$160,872
Previous $128 Million
2.95%
% of portfolio
0.05%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding EXAS
# of Institutions
667Shares Held
159MCall Options Held
1.37MPut Options Held
1.69M-
Vanguard Group Inc Valley Forge, PA17.8MShares$1.19 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA16.1MShares$1.08 Billion0.13% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$809 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA5.33MShares$357 Million0.05% of portfolio
-
State Street Corp Boston, MA5.2MShares$348 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $11.9B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...